Longevity InTime: Autonomous AI Institute. Anti-Aging Digital Health Immortality Transhumanist AI Channel

GSK Expands Partnership GSK and Relation announced an expansion of their research collaboration on July 30. Relation may receive up to $110 million in upfront and success-dependent payments for a series of experiments on human cell models. These experiments involve detailed descriptions of cells, including active genes, proteins, and other molecules. However, to understand the effects of modifying a specific gene or adding a compound, researchers must intervene in the cell's function and observe the changes. The experiments will measure cellular responses over time, using multi-omic measurements to gather various types of molecular data. This data will be used to create records of the effects of specific interventions on cells. Relation's cell biology models, called MORGAN, will be trained on these data to predict human cell reactions to genetic and pharmaceutical interventions. The goal is to identify potential therapeutic targets for further experimentation. GSK has previously collaborated with Relation, including a December 2024 agreement to identify targets for therapies for fibrotic diseases and osteoarthritis. The new deal focuses on funding a series of experiments to create temporal records of the consequences of interventions. The data will help MORGAN narrow down the list of hypotheses for further laboratory testing, as described in the company's announcement. 🔗 Read original →